Attenuated HIV-1 Nef But Not Vpu Function in a Cohort of Rwandan Long-Term Survivors.

CD4 HIV non-progressors HLA downregulation immune evasion pathogenesis tetherin viral accessory proteins

Journal

Frontiers in virology (Lausanne, Switzerland)
ISSN: 2673-818X
Titre abrégé: Front Virol
Pays: Switzerland
ID NLM: 9918334884106676

Informations de publication

Date de publication:
Jun 2022
Historique:
entrez: 19 8 2022
pubmed: 20 8 2022
medline: 20 8 2022
Statut: ppublish

Résumé

HIV-1 accessory proteins Nef and Vpu enhance viral pathogenesis through partially overlapping immune evasion activities. Attenuated Nef or Vpu functions have been reported in individuals who display slower disease progression, but few studies have assessed the relative impact of these proteins in non-B HIV-1 subtypes or examined paired proteins from the same individuals. Here, we examined the sequence and function of matched Nef and Vpu clones isolated from 29 long-term survivors (LTS) from Rwanda living with HIV-1 subtype A and compared our results to those of 104 Nef and 62 Vpu clones isolated from individuals living with chronic untreated HIV-1 subtype A from the same geographic area.

Identifiants

pubmed: 35982753
doi: 10.3389/fviro.2022.917902
pmc: PMC9383652
mid: NIHMS1828549
pii:
doi:

Types de publication

Journal Article

Langues

eng

Subventions

Organisme : NIMH NIH HHS
ID : R01 MH054907
Pays : United States
Organisme : NIAID NIH HHS
ID : UM1 AI164565
Pays : United States
Organisme : NIH HHS
ID : P51 OD011132
Pays : United States
Organisme : NIAID NIH HHS
ID : P30 AI027763
Pays : United States
Organisme : Wellcome Trust
Pays : United Kingdom

Déclaration de conflit d'intérêts

Conflict of Interest: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Références

Cell Host Microbe. 2008 Jun 12;3(6):388-98
pubmed: 18541215
Virology. 2014 Nov;468-470:214-225
pubmed: 25193656
PLoS Pathog. 2014 Jan;10(1):e1003895
pubmed: 24465210
J Virol. 2002 Jun;76(12):5959-65
pubmed: 12021328
Science. 2007 Aug 17;317(5840):944-7
pubmed: 17641165
PLoS One. 2015 Mar 20;10(3):e0120434
pubmed: 25793728
Syst Biol. 2010 May;59(3):307-21
pubmed: 20525638
PLoS Biol. 2017 Jun 12;15(6):e2001855
pubmed: 28604782
Retrovirology. 2014 Feb 06;11:15
pubmed: 24498878
Viruses. 2018 Oct 19;10(10):
pubmed: 30347660
J Virol. 2000 May;74(9):4361-76
pubmed: 10756051
Nat Rev Immunol. 2013 Jul;13(7):487-98
pubmed: 23797064
Retrovirology. 2013 Sep 16;10:100
pubmed: 24041011
Curr Opin HIV AIDS. 2021 Sep 1;16(5):243-248
pubmed: 34270465
Curr Opin Virol. 2013 Dec;3(6):692-9
pubmed: 24246762
Nat Struct Mol Biol. 2020 Sep;27(9):822-828
pubmed: 32719457
Bioinformatics. 2014 Nov 15;30(22):3276-8
pubmed: 25095880
AIDS Rev. 2021 Jan 12;24(2):51-58
pubmed: 35020715
J Virol. 2015 Sep;89(18):9639-52
pubmed: 26178998
BMJ. 1992 Jun 20;304(6842):1605-9
pubmed: 1628088
AIDS Res Hum Retroviruses. 1995 Nov;11(11):1413-6
pubmed: 8573400
J Virol. 2014 Dec;88(24):14241-57
pubmed: 25275127
Science. 1996 Sep 27;273(5283):1856-62
pubmed: 8791590
Public Health. 2016 Oct;139:3-12
pubmed: 27349729
Retrovirology. 2013 Jan 07;10:1
pubmed: 23289738
AIDS. 2014 Jan 14;28(2):149-62
pubmed: 24149086
J Virol. 2015 Jan;89(1):545-51
pubmed: 25339767
Viruses. 2016 Mar 03;8(3):67
pubmed: 26950141
Bioinformatics. 2001 May;17(5):415-8
pubmed: 11331235
Adv Pharmacol. 2007;55:389-409
pubmed: 17586321
Front Immunol. 2013 Dec 24;4:355
pubmed: 24400003
J Virol. 2000 Nov;74(22):10581-8
pubmed: 11044102
Infect Dis Clin North Am. 2000 Dec;14(4):809-25, v-vi
pubmed: 11144640
Viruses. 2021 Jul 27;13(8):
pubmed: 34452331
J Virol Methods. 2017 Feb;240:32-41
pubmed: 27865749
J Virol. 2020 Jul 1;94(14):
pubmed: 32376625
PLoS Pathog. 2020 Sep 14;16(9):e1008813
pubmed: 32925973
Virology. 2015 Aug;482:72-8
pubmed: 25827531
Cell. 1991 May 17;65(4):651-62
pubmed: 2032289
J Virol. 2014 Mar;88(5):2633-44
pubmed: 24352444
J Virol. 2019 Mar 5;93(6):
pubmed: 30602611
Proc Natl Acad Sci U S A. 2003 Aug 5;100(16):9440-5
pubmed: 12883005
Annu Rev Microbiol. 1996;50:825-54
pubmed: 8905100

Auteurs

Gisele Umviligihozo (G)

Faculty of Health Sciences, Simon Fraser University, Burnaby, BC, Canada.

Jaclyn K Mann (JK)

HIV Pathogenesis Programme, University of KwaZulu-Natal, Durban, South Africa.

Steven W Jin (SW)

Faculty of Health Sciences, Simon Fraser University, Burnaby, BC, Canada.

Francis M Mwimanzi (FM)

Faculty of Health Sciences, Simon Fraser University, Burnaby, BC, Canada.

Hua-Shiuan A Hsieh (HA)

Department of Molecular Biology and Biochemistry, Simon Fraser University, Burnaby, BC, Canada.

Hanwei Sudderuddin (H)

British Columbia Centre for Excellence in HIV/AIDS, Vancover, BC, Canada.

Guinevere Q Lee (GQ)

Department of Medicine, Weill Cornell Medical College, New York, NY, United States.

Helen Byakwaga (H)

Department of Community Health, Mbarara University of Science and Technology, Mbarara, Uganda.
Department of Medicine, University of California, San Francisco, CA, United States.

Conrad Muzoora (C)

Department of Medicine, Weill Cornell Medical College, New York, NY, United States.

Peter W Hunt (PW)

Department of Community Health, Mbarara University of Science and Technology, Mbarara, Uganda.

Jeff N Martin (JN)

Department of Community Health, Mbarara University of Science and Technology, Mbarara, Uganda.

Jessica E Haberer (JE)

Center for Global Health, Massachusetts General Hospital, Boston, MA, United States.
Department of Medicine, Harvard Medical School, Boston, MA, United States.

Etienne Karita (E)

Centre for Family Health Research, Kigali, Rwanda.

Susan Allen (S)

Department of Pathology and Laboratory Medicine, Emory University, Atlanta, GA, United States.

Eric Hunter (E)

Department of Pathology and Laboratory Medicine, Emory University, Atlanta, GA, United States.
Emory Vaccine Center at Yerkes National Primate Research Center, Atlanta, GA, United States.

Zabrina L Brumme (ZL)

Faculty of Health Sciences, Simon Fraser University, Burnaby, BC, Canada.
British Columbia Centre for Excellence in HIV/AIDS, Vancover, BC, Canada.

Mark A Brockman (MA)

Faculty of Health Sciences, Simon Fraser University, Burnaby, BC, Canada.
Department of Molecular Biology and Biochemistry, Simon Fraser University, Burnaby, BC, Canada.
British Columbia Centre for Excellence in HIV/AIDS, Vancover, BC, Canada.

Classifications MeSH